Background: More than 350,000 gonorrhea cases were reported nationally in 2014. National data reflect cases diagnosed, not the number of persons diagnosed. The contribution of repeat infections to overall case incidence has not been previously examined because national reporting data lack patient identifiers. We examined data from the STD Surveillance Network (SSuN), which allows individuals to be linked if diagnosed more than once, to describe characteristics of persons with repeat infections and assess their contributions to overall case incidence.
Methods: Enhanced surveillance data were analyzed to identify individuals diagnosed with gonorrhea more than once in nine SSuN jurisdictions during 2015. Diagnoses were classified as repeat infections if diagnosed >30 days apart for the same individual. We assessed the contribution of repeat diagnoses to case incidence and used generalized estimating equations to estimate the association between repeat diagnosis and selected patient demographics.
Results: During January–December 2015, 73,826 patients were diagnosed and reported with 78,211 cases of gonorrhea. Overall, 5.4% (3,997) of individuals had more than one diagnosis and these individuals contributed 10.7% (8,382) of all diagnoses reported in SSuN jurisdictions. Among those with repeat diagnoses, 8.7% had three or more episodes of gonorrhea identified during the study period (range: 2–6). After controlling for jurisdiction, males (adjusted odds ratio [aOR] 1.6, 95% CI: 1.5, 1.7), persons 25-29 years old (aOR 1.7, 95% CI: 1.5, 2.0), and non-Hispanic-whites (aOR 1.2, 95% CI: 1.0, 1.4) were more likely than females, other age groups, or other race/ethnicities to be reported with repeat infections.
Conclusions: Repeat diagnoses account for a substantial proportion of reported cases in SSuN jurisdictions. Targeting persons at increased risk for repeat infection with interventions, such as partner services, may reduce overall case burden and may identify persons with treatment failures. Persons with repeat infections may also be candidates for individual-level STD/HIV interventions, including PrEP.